Research Article
Volume 18 Issue 9 - 2022
Role of Colonization Resistance of Gastric and Intestinal Mucosa in the Development of Gastrointestinal Bacterial Infections

Chicherin IYu*1, Pogorelsky IP2, Kolodkin AM1, Lundovskikh IA2, Shabalina MR2 and Kolevatykh EP3

1Scientific society «Microbiota», Sergiev Posad, Moscow Region, Russian Federation

2Department of Microbiology, Institute of Biology and Biotechnology, Vyatka State University, Kirov, Russian Federation

3Department of Microbiology and Virology, Kirov State Medical University, Kirov, Russian Federation

*Corresponding Author: Chicherin IYu, Scientific society «Microbiota», Sergiev Posad, Moscow Region, Russian Federation.
Received: July 17, 2021; Published: May 02, 2022


The aim of the article is to analyze the role of colonization resistance of the gastric and intestinal mucosa in the development of bacterial gastrointestinal infections in conventional white mice. We created the experimental models of intestinal yersiniosis, pseudotuberculosis, salmonellosis and escherichiosis in conventional white mice by oral administration of bacterial suspensions containing pathogenic strains of Yersinia enterocolitica KM1407, Yersinia pseudotuberculosis KM07, Salmonella enteritidis KM08, Escherichia coli EG, isolated from patients with manifesting infectious diseases. Bacteriological methods were used to confirm bacterial engraftment and generalization of the infectious process. Pathological changes in the stomach and small intestine of dead animals were evaluated using histological sections of the stomach and small intestine. We measured the concentration of bacteria in the stomach and intestine after their single administration at a dose, required to cause symptomatic disease. Oral administration of the metaprebiotic Stimbifid plus (both preventive and therapeutic) to infected animals completely stopped the infectious process. Our findings indicate high therapeutic potential of metaprebiotic Stimbifid plus and its ability to preserve commensal microbiota and colonization resistance that play an essential role in the prevention of intestinal infections and ensure their termination in the early stage.


Keywords: Intestinal Yersiniosis; Pseudotuberculosis; Salmonellosis; Escherichiosis; Microbiota; Colonization Resistance; Stimbifid Plus; White Mice


  1. Liu L., et al. “Global, regional and national causes of child mortality: an updated systematic analyses for 2010 with him trends since 2000”. Lancet 379 (2012): 2151-2161.
  2. Ruzhentsova TA., et al. “Optimization of pathogenetic therapy of acute intestinal infections in children: results of a randomized trial”. Infectious Diseases 2 (2018): 70-76.
  3. Milyutina LN., et al. “Clinical and epidemiological aspects of the evolution of rotavirus infection in children”. Infectious Diseases 2 (2018): 6-10.
  4. Gracheva NM., et al. “Fructooligosaccharides and fructopolysaccharides in the complex treatment of patients with gastrointestinal diseases with symptoms of intestinal dysbiosis”. Infectious Diseases1 (2010): 107-111.
  5. Chicherin IYu., et al. “Study of the effect of large doses of the probiotic Bifidumbacterin and microorganisms of intestinal autoflora on the body of white mice and indicators of cellular immunity”. Medical Advisor of the Volga Region 1 (2013): 85-90.
  6. Zakharenko SM., et al. “Infections, human intestinal microbiota and metabolic syndrome”. Effective pharmacotherapy”. Gastroenterology 3 (2012): 14-20.
  7. Somov GP., et al. “Pseudotuberculosis”. 2nd edition. revised and add. M.: Medicine (2001): 256.
  8. Yushchuk ND., et al. “Yersiniosis”. M.: Medicine (2003): 208.
  9. Yushchuk ND., et al. “Yersiniosis. In the book: Lectures on infectious diseases. In 2 volumes. Volume 1”. -2nd edition. revised and add. Moscow: VUNMTs (1999): 454.
  10. Yushchuk ND., et al. “Yersiniosis as a surgical problem”. Surgery 12 (1999): 50-52.
  11. Sedelnikova SM., et al. “Yersiniosis as a therapeutic problem”. Therapeutic Archive 11 (2000): 27-30.
  12. Sorrells KM., et al. “Pathogenicity of Salmonella gallinarum after metabolic injury by freezing”. Applied and Environmental Microbiology1 (1970): 39-43.
  13. Guide to Infectious Diseases/Edition. Yu.V. Lobzin. SPb.: Foliant (2000): 932.
  14. Medical Microbiology / Edition. A.M. Korolyuk, V.B. Sboychakova. SPb.: ZAO ELBI (1999): 272.
  15. Pepe JC., et al. “Yersinia enterocolitica invasion: a primary role in the initiation of infection”. Proceedings of the National Academy of Sciences of the United States of America 90 (1993): 6473-6477.
  16. Darwin A., et al. “Identification of Yersinia enterocolitica genes affecting survival in an animal host using signature tagget transposon mutagenesis”. Molecular Microbiology 32 (1999): 51-62.
  17. Tseneva GYa., et al. “The choice of models for determining the pathogenic properties of the causative agent of pseudotuberculosis”. Journal of Microbiology 11 (1982): 68-71.
  18. Tseneva GYa., et al. “Characteristics of the invasiveness of the causative agent of pseudotuberculosis”. Journal of Microbiology 5 (1984): 26-30.
  19. Glushanova NA., et al. “The relationship of probiotic and indigenous lactobacilli of the host in conditions of co-cultivation in vitro”. Journal of Microbiology 2 (2005): 56-61.
  20. Minushkin ON., et al. “Microflora imbalance and its correction”. Effective Pharmacotherapy. Gastroenterology 4 (2013): 4-8.
  21. Savina VE., et al. “Colonization resistance of the intestine”. Society, Science, Innovation (NPK-2013). Collection of materials. Kirov: Publishing house of Vyatka State University (2013): 76-78.
  22. Zvyagintseva TD., et al. “Correction of violations of intestinal colonization resistance”. URL (2021).
  23. Shenderov BA. “Medical microbial ecology and functional nutrition: in 3 volumes. Vol. 1: Human and animal microflora and its functions”. M.: GRANT. 1998. 288 с.
  24. Shenderov BA. “Normal microflora and its role in maintaining human health”. Journal of Gastroenterology, Hepatology, Coloproctology1 (1998):61-65.
  25. Lammers KM., et al. “Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells”. FEMS Immunology  Medical Microbiology2 (2003):165-172.
  26. Veckman V., et al. “Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th 1 cell chemotaxis”. Journal of Leukocyte Biology3 (2003): 395-402.
  27. Maraculin IV., et al. “Design of pseudotuberculosis microbial strain that is promising for obtaining a polyvalent vaccine”. Biotechnology in Russia 4 (2004):83-89.
  28. Darmov IV., et al. “Prevention of experimental pseudotuberculosis infection by immunization with porin from Yersinia pseudotuberculosis”. Bulletin of Experimental Biology and Medicine2 (1999): 221-223.
  29. Harseeva GG., et al. “Suppression of bacterial adhesion: current problems, approaches, prospects”. Advances in Modern Biology5 (2019): 506-515.
  30. Pogorelsky IP., et al. “A method for modeling helicobacteriosis”. RF patent No. 2690943 dated 06.07.2019, publ. 07.06.2019. bul. No. 16. Number of the title of protection G09B 23/28 (2019).
  31. Chicherin IYu., et al. “Evaluation of the eradication efficiency of the metaprebiotic Stimbifid plus in acute experimental helicobacteriosis in laboratory animals and human volunteers”. Infectious Diseases4 (2018):62-74.
  32. Cremniter J., et al. “Th-17 response and antimicrobial peptide expression in gastric mucosa of Helicobacter pylori – infected patients independently of their clinical outcomes”. 23.3.
  33. Chicherin Yu., et al. “Colonization resistance of the intestinal mucosa in experimental yersiniosis”. Journal of Infectology1 (2013):75-82.
  34. Marakulin IV., et al. “Experimental model of pseudotuberculosis infection in monkeys”. Bulletin of Experimental Biology and Medicine 7 (1994): 59-62.
  35. Chicherin IYu., et al. “Experimental pseudotuberculosis: assessment of the possibility of prevention, treatment and correction of dysbiotic disorders of the intestinal microflora”. Journal of Infectology4 (2012): 71-79.
  36. Bondarenko VM., et al. Methodical recommendations "Microbiological diagnosis of intestinal dysbiosis". M.: GU NIIEM im. N.F. Gamalei RAMS (2007): 72.
  37. Ashmarin IP., et al. “Statistical methods in microbiological research. L.: Medgiz (1962): 280.
  38. Reid G., et al. “Microbiota restoration: natural and supplement recovery of human microbial communities”. Nature Reviews Microbiology1 (2011): 27-38.
  39. Podkolzin AT., et al. “Analysis of the structure of deaths in young children with acute intestinal infections”. Infectious Diseases2 (2013): 38-44.
  40. Mavzyutov AR., et al. “Factors of pathogenicity of opportunistic enterobacteria and their role in the development of diarrhea”. Journal of Microbiology, Epidemiology and Immunobiology 1 (2007):89-96.
  41. Malfertheiner P., et al. “Management of Helicobacter pylori infection – the Maastricht V”. Florence Cobsrnsus Report Gut (2016).
  42. Pimanov SI., et al. “Recommendations of Maastricht V / Florentine Consensus for the treatment of Helicobacter pylori infection”. Consilium Medicum1 (2017): 8-21.
  43. Dang Y., et al. “The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a mata-analysis”. PloS One11 (2014): е111030.
  44. Pimanov SI., et al. “Optimized eradication protocols: recommendations of the American College of Gastroenterologists, Maastricht V/Florence and Toronto Consensus”. Medical Advice 5 (2017): 10-17.
  45. Bondareva TA., et al. “Current state and prospects of solving the problem of increasing the effectiveness of emergency prevention and treatment of systemic bacterial infections”. Molecular Medicine 5 (2009): 21-25.
  46. Gasbarrini G., et al. “The role of bacterial flora and its products in the functioning of the small intestine”. Digestive and Liver Disease Supplement1 (2007): 3-6.
  47. Eckburg PB., et al. “Diversity of the human intestinal micrоbial flora”. Science5728 (2005): 1635-1638.
  48. Nikolaeva IV., et al. “Formation of a child's intestinal microbiota and factors affecting this process”. Russian Bulletin of Perinatology and Pediatrics3 (2018): 13-18.
  49. Murzabaeva RT., et al. “Clinical and immunological parallels in acute intestinal infections caused by opportunistic enterobacteria”. Infectious Diseases4 (2018):79-85.
  50. Khavkin AI. “Experience of using the probiotic L. rhamnosus GG strain in pediatrics”. Journal of International Medicine11 (2014):101-106.
  51. Minushkin OV., et al. “The first experience of using metaprebiotic therapy in the eradication of Helicobacter pylori”. Kremlin Medicine Clinical Bulletin 2 (2019): 36-38.
  52. Shenderov BA., et al. “Metabiotics: yesterday, today, tomorrow”. SPb.: Kraft (2017): 80.
Citation: Chicherin IYu., et al. “Role of Colonization Resistance of Gastric and Intestinal Mucosa in the Development of Gastrointestinal Bacterial Infections”. EC Microbiology 18.9 (2022): 33-48.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

February Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the February issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before February 17, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.